Boston Scientific (BSX) Share-based Compensation (2016 - 2025)
Historic Share-based Compensation for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $71.0 million.
- Boston Scientific's Share-based Compensation rose 289.86% to $71.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $299.0 million, marking a year-over-year increase of 1240.6%. This contributed to the annual value of $299.0 million for FY2025, which is 1240.6% up from last year.
- Boston Scientific's Share-based Compensation amounted to $71.0 million in Q4 2025, which was up 289.86% from $79.0 million recorded in Q3 2025.
- Boston Scientific's 5-year Share-based Compensation high stood at $79.0 million for Q3 2025, and its period low was $47.0 million during Q1 2021.
- Moreover, its 5-year median value for Share-based Compensation was $59.0 million (2023), whereas its average is $60.6 million.
- Its Share-based Compensation has fluctuated over the past 5 years, first surged by 2750.0% in 2021, then soared by 172.41% in 2023.
- Boston Scientific's Share-based Compensation (Quarter) stood at $49.0 million in 2021, then increased by 12.24% to $55.0 million in 2022, then grew by 7.27% to $59.0 million in 2023, then rose by 16.95% to $69.0 million in 2024, then rose by 2.9% to $71.0 million in 2025.
- Its Share-based Compensation was $71.0 million in Q4 2025, compared to $79.0 million in Q3 2025 and $75.0 million in Q2 2025.